Dr. Kinoshita is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave NW
Washington, DC 20010Phone+1 202-476-5000
Education & Training
- University of HawaiiResidency, Pediatrics, 2015 - 2018
- University College Cork Faculty of MedicineClass of 2015
Certifications & Licensure
- DC State Medical License 2019 - 2025
- HI State Medical License 2018 - 2020
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 5 citationsDurable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita
Blood Advances. 2024-03-12 - 4 citationsCD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?Hannah Kinoshita, Catherine M Bollard, Keri Toner
Seminars in Hematology. 2023-11-01 - 3 citationsOutcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease.Hannah Kinoshita, Mamatha Mandava, Mariah Jensen-Wachspress, Haili Lang, Elisabeth Joy
Blood Advances. 2023-05-23
Press Mentions
- SARS-CoV-2-Specific T-cell Responses Are Amplified in Children with Multisystem Inflammatory Syndrome in ChildrenAugust 27th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: